Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1149-1158
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1149
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1149
Figure 1 Study design.
A: Flow chart; B: Swimmer plot of the 32 patients. PMP: Pseudomyxoma peritonei; CC: Completeness of cytoreduction; Bev+CTX+OXA: Bevacizumab combined with cyclophosphamide and oxaliplatin; CRS: Cytoreductive surgery; HIPEC: Hyperthermic intraperitoneal chemotherapy.
- Citation: Zhang Y, Zhao X, Gao C, Lin LY, Li Y. Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei. World J Gastrointest Surg 2023; 15(6): 1149-1158
- URL: https://www.wjgnet.com/1948-9366/full/v15/i6/1149.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i6.1149